Search Page

1

Cite

Share

Cost Analysis of FreeStyle Libre^® 2 System in Type 2 Diabetes Mellitus Population.

Oyagüez I, Gómez-Peralta F, Artola S, Carrasco FJ, Carretero-Gómez J, García-Soidan J, Gómez-Huelgas R, Merino-Torres JF, Pérez A. Oyagüez I, et al. Diabetes Ther. 2021 Sep;12(9):2329-2342. doi: 10.1007/s13300-021-01064-4. Epub 2021 May 4. Diabetes Ther. 2021. PMID: 33948909 Free PMC article.

Cite

Share

2

Cite

Share

[Efficiency of oncologic treatments for solid tumours in Spain].

Oyagüez I, Frías C, Seguí MÁ, Gómez-Barrera M, Casado MÁ, Queralt Gorgas M. Oyagüez I, et al. Farm Hosp. 2013 May-Jun;37(3):240-59. doi: 10.7399/FH.2013.37.3.570. Farm Hosp. 2013. PMID: 23789801 Free article. Review. Spanish.

Cite

Share

3

Cite

Share

Fe de errores de<<Impacto presupuestario de una combinación a dosis fija de efavirenz-emtricitabina-tenofovir para tratamiento de pacientes infectados por el virus de la inmunodeficiencia humana tipo 1>>

Oyagüez I, Casado MA, Cotarelo M, Ramírez-Arellano A, Mallolas J. Oyagüez I, et al. Farm Hosp. 2010 Aug 7. doi: 10.1016/j.farma.2010.07.002. Online ahead of print. Farm Hosp. 2010. PMID: 20696608 Free article. Spanish. No abstract available.

Cite

Share

4

Cite

Share

Cost effectiveness of prostacyclins in pulmonary arterial hypertension.

Roman A, Barberà JA, Escribano P, Sala ML, Febrer L, Oyagüez I, Sabater E, Casado MA. Roman A, et al. Among authors: oyaguez i. Appl Health Econ Health Policy. 2012 May 1;10(3):175-88. doi: 10.2165/11630780-000000000-00000. Appl Health Econ Health Policy. 2012. PMID: 22452448 Review.

Cite

Share

5

Cite

Share

Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review.

Echave M, Oyagüez I, Casado MA. Echave M, et al. Among authors: oyaguez i. BMC Surg. 2014 Dec 20;14:111. doi: 10.1186/1471-2482-14-111. BMC Surg. 2014. PMID: 25528250 Free PMC article. Review.

Cite

Share

6

Cite

Share

Correction to: Cost Analysis of FreeStyle Libre^® 2 System in Type 2 Diabetes Mellitus Population.

Oyagüez I, Gómez-Peralta F, Artola S, Carrasco FJ, Carretero-Gómez J, García-Soidan J, Gómez-Huelgas R, Merino-Torres JF, Pérez A. Oyagüez I, et al. Diabetes Ther. 2021 Aug;12(8):2263-2264. doi: 10.1007/s13300-021-01093-z. Diabetes Ther. 2021. PMID: 34241813 Free PMC article. No abstract available.

Cite

Share

7

Cite

Share

Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review.

Buti M, Oyagüez I, Lozano V, Casado MA. Buti M, et al. Among authors: oyaguez i. Pharmacoeconomics. 2013 Jan;31(1):63-75. doi: 10.1007/s40273-012-0009-2. Pharmacoeconomics. 2013. PMID: 23329593 Review.

Cite

Share

8

Cite

Share

Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain.

Calleja MA, Albanell J, Aranda E, García-Foncillas J, Feliu A, Rivera F, Oyagüez I, Salinas-Ortega L, Soto Alvarez J. Calleja MA, et al. Among authors: oyaguez i. Eur J Hosp Pharm. 2021 Nov 22:ejhpharm-2021-002955. doi: 10.1136/ejhpharm-2021-002955. Online ahead of print. Eur J Hosp Pharm. 2021. PMID: 34810173

Cite

Share

9

Cite

Share

Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain.

Ibáñez R, Mareque M, Granados R, Andía D, García-Rojo M, Quílez JC, Oyagüez I. Ibáñez R, et al. Among authors: oyaguez i. BMC Womens Health. 2021 Apr 26;21(1):178. doi: 10.1186/s12905-021-01310-8. BMC Womens Health. 2021. PMID: 33902553 Free PMC article.

Cite

Share

10

Cite

Share

Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain.

Alsina L, Montoro JB, Moral PM, Neth O, Pica MO, Sánchez-Ramón S, Presa M, Oyagüez I, Casado MÁ, González-Granado LI. Alsina L, et al. Among authors: oyaguez i. Eur J Health Econ. 2022 Apr;23(3):551-558. doi: 10.1007/s10198-021-01378-x. Epub 2021 Sep 21. Eur J Health Econ. 2022. PMID: 34546485 Free PMC article.

Cite

Share